SARS-COV-2 RECOMBINANT SPIKE PROTEIN — all Canadian products
3 DINs
1 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is SARS-COV-2 RECOMBINANT SPIKE PROTEIN, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02558998 | NUVAXOVID | SANOFI VACCINES CANADA LTD. | Suspension | Intramuscular | SARS-COV-2 RECOMBINANT SPIKE PROTEIN 5 MCG | Approved | |
| 02525364 | NUVAXOVID | NOVAVAX INC. | Suspension | Intramuscular | SARS-COV-2 RECOMBINANT SPIKE PROTEIN 5 MCG | Cancelled Post Market | |
| 02543656 | NUVAXOVID | SANOFI VACCINES CANADA LTD. | Suspension | Intramuscular | SARS-COV-2 RECOMBINANT SPIKE PROTEIN 5 MCG | Dormant |
Browse other molecules: